BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21957976)

  • 1. The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
    Pan XD; Zeng ZH; Liang LY; Luo JD; Xiao AY; Lai Q; Wen YH; Lu DF; Wang W; He ZC; He WK
    Clin Exp Hypertens; 2011; 33(8):558-64. PubMed ID: 21957976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension.
    Ivanova OV; Fomicheva OA; Sergakova LM; Chernova NA; Rogoza AN; Karpov YA
    J Int Med Res; 2005; 33 Suppl 1():21A-29A. PubMed ID: 16222897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan.
    Mattioli AV; Zennaro M; Bonatti S; Bonetti L; Mattioli G
    Int J Cardiol; 2004 Dec; 97(3):383-8. PubMed ID: 15561322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension.
    Mattioli AV; Bonatti S; Monopoli D; Zennaro M; Mattioli G
    Blood Press; 2005; 14(5):273-8. PubMed ID: 16257872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
    Wang HB; Shi Q; Zhang C
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.
    Cicero AF; Veronesi M; Prandin MG; Di Gregori V; Ambrosioni E; Borghi C
    Fundam Clin Pharmacol; 2009 Oct; 23(5):583-8. PubMed ID: 19555395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Fallahi P; Tocchini L; Graci F; Carpi A; Antonelli A; Santoro G
    Biomed Pharmacother; 2010 Oct; 64(8):516-20. PubMed ID: 20044234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan.
    Fountoulaki K; Dimopoulos V; Giannakoulis J; Zintzaras E; Triposkiadis F
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):171-7. PubMed ID: 15752943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.
    Hinoi T; Tomohiro Y; Kajiwara S; Matsuo S; Fujimoto Y; Yamamoto S; Shichijo T; Ono T
    Hypertens Res; 2008 Apr; 31(4):615-22. PubMed ID: 18633172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of telmisartan on left ventricular structure and function in patients with hypertension determined by two-dimensional strain imaging.
    Mizuguchi Y; Oishi Y; Miyoshi H; Iuchi A; Nagase N; Oki T
    J Hypertens; 2009 Sep; 27(9):1892-9. PubMed ID: 19506525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
    Galzerano D; Tammaro P; Cerciello A; Breglio R; Mallardo M; Lama D; Tuccillo B; Capogrosso P
    J Hum Hypertens; 2004 Jan; 18(1):53-9. PubMed ID: 14688811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
    Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
    Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O; Metelka R; Vymetal J; Konecný K; Kosatíková Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):69-73. PubMed ID: 15523550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.